Filed 1mo ago· Apr 17, 2026
24 days to disclose
Laura Friedman
DHouseCalifornia-30
↔exchanged
Abbott Laboratories
ABT
$1K-$15K
Trade dateMar 24, 2026
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.







































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 17, 2026 1mo ago | ![]() Laura Friedman DHouseCalifornia-30 | ↔exchanged | Abbott Laboratories ABT | Mar 24, 2026 24 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | ![]() Richard McCormick RHouseGeorgia-07 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Investigations and Oversight | Mar 19, 2026 19 days to disclose | Bad buy·−$1.6K-19.5% −20.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2026 2mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Abbott Laboratories ABT | Feb 10, 2026 27 days to disclose | Flat·+0.0% −4.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 19, 2026 3mo ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Energy and Commerce | Jan 29, 2026 21 days to disclose | Bad buy·−$1.5K-18.7% −15.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2026 4mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Abbott Laboratories ABT | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | ![]() Julia Letlow RHouseLouisiana-05 | ↓sold | Abbott Laboratories ABT | Dec 8, 2025 36 days to disclose | Flat·+0.0% −1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | ![]() Julia Letlow RHouseLouisiana-05 | ↑bought | Abbott Laboratories ABT | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Bad buy·−$2.1K-26.2% −25.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Abbott Laboratories ABT | Dec 19, 2025 24 days to disclose | Flat·+0.0% −4.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 7, 2026 4mo ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Abbott Laboratories ABT | Dec 4, 2025 34 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 7, 2026 4mo ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Abbott Laboratories ABT | Dec 4, 2025 34 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Abbott Laboratories ABT | Nov 18, 2025 27 days to disclose | Bad buy·−$2.7K-33.6% −30.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Abbott Laboratories ABT | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2025 5mo ago | ![]() Richard McCormick RHouseGeorgia-07 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Investigations and Oversight | Nov 5, 2025 34 days to disclose | Bad buy·−$2.5K-30.7% −32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 16, 2025 7mo ago | ![]() Rick Larsen DHouseWashington-02 | ↑bought | Abbott Laboratories ABT | Oct 6, 2025 10 days to disclose | Bad buy·−$2.8K-35.5% −38.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 17, 2025 8mo ago | ![]() Richard McCormick RHouseGeorgia-07 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Investigations and Oversight | Mar 15, 2023 917 days to disclose · 872 past 45-day window | Bad buy·−$941-11.8% −29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Abbott Laboratories ABT | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Energy and Commerce | Jul 21, 2025 30 days to disclose | Bad buy·−$2.5K-30.6% −43.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Health, Employment, Labor, and Pensions | Jul 10, 2025 34 days to disclose | Flat·+0.0% +8.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Health, Employment, Labor, and Pensions | Jun 24, 2025 50 days to disclose · 5 past 45-day window | Bad buy·−$3K-37.5% −48.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 11, 2025 9mo ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Abbott Laboratories ABT | Jul 18, 2025 24 days to disclose | Flat·+0.0% +12.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Abbott Laboratories ABT | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $50K-$100K midpoint $75K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | Abbott Laboratories ABT | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Abbott Laboratories ABT | Mar 3, 2025 44 days to disclose | Bad buy·−$3.1K-38.5% −37.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↑bought | Abbott Laboratories ABT | Mar 20, 2025 25 days to disclose | Bad buy·−$2.6K-31.9% −32.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↑bought | Abbott Laboratories ABT | Mar 20, 2025 25 days to disclose | Bad buy·−$2.6K-31.9% −32.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2025 1.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Abbott Laboratories ABT | Mar 6, 2025 35 days to disclose | Flat·+0.0% −0.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | ![]() Shelley Moore Capito RSenateWest Virginia | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Commerce, Science, and Transportation | Feb 24, 2025 10 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Abbott Laboratories ABT | Feb 13, 2025 21 days to disclose | Bad buy·−$2.8K-34.5% −36.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2025 1.3y ago | ![]() Emily Randall DHouseWashington-06 | ↓sold | Abbott Laboratories ABT | Jan 6, 2025 36 days to disclose | Flat·+0.0% +6.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Abbott Laboratories ABT | Jan 29, 2025 12 days to disclose | Bad buy·−$2.6K-32.5% −34.5% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Abbott Laboratories ABT | Jan 28, 2025 13 days to disclose | Bad buy·−$2.6K-32.3% −33.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Oversight | Jan 15, 2025 26 days to disclose | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Oversight | Jan 15, 2025 26 days to disclose | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Oversight | Jan 15, 2025 26 days to disclose | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 31, 2025 1.3y ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Abbott Laboratories ABT | Jan 8, 2025 23 days to disclose | Flat·+0.0% +5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 22, 2025 1.4y ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Energy and Commerce | Dec 16, 2024 37 days to disclose | Bad buy·−$1.9K-23.4% −30.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 31, 2024 1.4y ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Abbott Laboratories ABT | Dec 11, 2024 20 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 11, 2024 1.7y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Abbott Laboratories ABT | Aug 19, 2024 23 days to disclose | Bad buy·−$1.8K-22.9% −19.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | ![]() John James RHouseMichigan-10 | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | ![]() John James RHouseMichigan-10 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Bad buy·−$653-8.2% −25.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Oversight | Feb 13, 2024 190 days to disclose · 145 past 45-day window | Flat·+0.0% +4.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 19, 2024 1.8y ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Energy and Commerce | Jul 23, 2024 27 days to disclose | Bad buy·−$915-11.4% −40.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 19, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Oversight | Jul 5, 2024 45 days to disclose | Bad buy·−$1.4K-17.0% −19.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Abbott Laboratories ABT | Jul 2, 2024 45 days to disclose | Bad buy·−$1.3K-16.4% −19.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Abbott Laboratories ABT | Jul 2, 2024 45 days to disclose | Bad buy·−$1.3K-16.4% −19.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 15, 2024 1.8y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Abbott Laboratories ABT | Jul 29, 2024 17 days to disclose | Bad buy·−$972-12.2% −43.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Abbott Laboratories ABT | Jan 23, 2024 14 days to disclose | Bad buy·−$1.9K-24.3% −30.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↓sold | Abbott Laboratories ABT | Jan 23, 2024 14 days to disclose | Flat·+0.0% +6.1% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 2, 2024 2.3y ago | ![]() Thomas R Carper DSenateDelaware | ↓sold | Abbott Laboratories ABT | Jan 17, 2024 16 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2023 2.5y ago | ![]() John R. Curtis RSenateUtah | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Commerce, Science, and Transportation | Dec 4, 2023 11 days to disclose | Smart sell·+$1.1K+13.4% +69.7% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Abbott Laboratories ABT | Oct 3, 2023 29 days to disclose | Bad buy·−$389-4.9% −74.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 20, 2023 2.6y ago | ![]() Pete Ricketts RSenateNebraska | ↓sold | Abbott Laboratories ABT | Sep 21, 2023 29 days to disclose | Smart sell·+$13.8K+7.9% +73.4% vs S&P 500 | $100K-$250K midpoint $175K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Abbott Laboratories ABT | Sep 13, 2023 29 days to disclose | Bad buy·−$3.7K-11.3% −71.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 4, 2023 2.7y ago | ![]() John R. Curtis RSenateUtah | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Commerce, Science, and Transportation | Sep 13, 2023 21 days to disclose | Smart sell·+$901+11.3% +71.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2023 2.8y ago | ![]() Rick W. Allen RHouseGeorgia-12 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Health, Employment, Labor, and Pensions | May 12, 2020 1185 days to disclose · 1140 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
May 19, 2023 3.0y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↓sold | Abbott Laboratories ABT | Apr 28, 2023 21 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | ![]() Daniel S. Goldman DHouseNew York-10 | ↑bought | Abbott Laboratories ABT | Mar 7, 2023 41 days to disclose | Bad buy·−$994-12.4% −29.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 9, 2022 3.6y ago | ![]() John R. Curtis RSenateUtah | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Commerce, Science, and Transportation | Oct 21, 2022 19 days to disclose | Bad buy·−$331-4.1% −94.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 3, 2022 3.6y ago | ![]() Thomas R Carper DSenateDelaware | ↑bought | Abbott Laboratories ABT | Oct 17, 2022 17 days to disclose | Bad buy·−$958-12.0% −106.6% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2022 3.6y ago | ![]() David B. McKinley —HouseWest Virginia-01 | ↑bought | Abbott Laboratories ABT | Sep 21, 2022 21 days to disclose | Bad buy·−$1.1K-14.3% −35.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2022 3.8y ago | ![]() Carol D. Miller RHouseWest Virginia-01 | ↑bought | Abbott Laboratories ABT ⚑ Healthcare · Ways and Means | Mar 4, 2021 547 days to disclose · 502 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Aug 10, 2022 3.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Abbott Laboratories ABT | Jul 27, 2022 14 days to disclose | Bad buy·−$1.7K-21.5% −34.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Abbott Laboratories ABT | Jul 27, 2022 14 days to disclose | Bad buy·−$1.7K-21.5% −34.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↑bought | Abbott Laboratories ABT | Jul 15, 2022 26 days to disclose | Bad buy·−$1.7K-20.9% −35.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Abbott Laboratories ABT | Jul 15, 2022 26 days to disclose | Bad buy·−$1.7K-20.9% −35.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Abbott Laboratories ABT | Jul 15, 2022 26 days to disclose | Bad buy·−$1.7K-20.9% −35.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 8, 2022 3.9y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↑bought | Abbott Laboratories ABT | Jun 16, 2022 22 days to disclose | Bad buy·−$1.2K-15.5% −39.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 13, 2022 4.1y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↓sold | Abbott Laboratories ABT | Apr 19, 2022 24 days to disclose | Flat·+0.0% +7.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 9, 2022 4.2y ago | ![]() Robert J. Wittman RHouseVirginia-01 | ↑bought | Abbott Laboratories ABT | Mar 29, 2022 11 days to disclose | Bad buy·−$2.3K-28.2% −35.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 31, 2021 4.4y ago | ![]() Michael C. Burgess —HouseTexas-26 | ↓sold | Abbott Laboratories ABT | Nov 19, 2021 42 days to disclose | Smart sell·+$9.2K+28.2% +80.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Nov 18, 2021 4.5y ago | ![]() Kim Schrier DHouseWashington-08 | ↓sold | Abbott Laboratories ABT ⚑ Healthcare · Energy and Commerce | Oct 28, 2021 21 days to disclose | price pending | $15K-$30K midpoint $22.5K |